Performance analysis of Sonoma Pharmaceuticals (SNOA)
Annual Return
Over the past 3 years, SNOA has had an average annual return of -43.19%, underperforming the benchmark SPY, which returned +20.51% annual.
Over the past 5 years, SNOA has had an average annual return of -51.09%, underperforming the benchmark SPY, which returned +13.50% annual.
Over the past 10 years, SNOA has had an average annual return of -40.94%, underperforming the benchmark SPY, which returned +15.42% annual.
Since Jan 25, 2007, SNOA has had an average annual return of -38.03%, underperforming the benchmark SPY, which returned +10.90% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | +0% | +0% | -80.00% | -73.68% | -36.67% | +66.67% | -30.77% | -87.00% | +8.11% | -12.32% | -19.47% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||
| -58.87% | -18.54% | -41.90% | -37.89% | -7.63% | +27.99% | -65.13% | -47.44% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +0% | +0% | +0% | +0% | ||||||||
| 2025 | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% |
| 2024 | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% |
| 2023 | +40% | -28.57% | -20.00% | +0% | +0% | -0% | +0% | +0% | -25.00% | -66.67% | +0% | +0% | -80.00% |
| 2022 | -21.05% | -13.33% | +23.08% | -31.25% | +27.27% | -14.29% | +0% | -8.33% | -18.18% | -11.11% | -12.50% | -28.57% | -73.68% |
| 2021 | +10% | +0% | -9.09% | +6.67% | -3.13% | -3.23% | -10.00% | -3.70% | -11.54% | +4.35% | -8.33% | -13.64% | -36.67% |
| 2020 | +16.67% | +0% | -4.76% | +5% | +85.71% | -25.64% | +27.59% | -18.92% | +13.33% | -11.76% | -10.00% | +11.11% | +66.67% |
| 2019 | +3.85% | +25.93% | -0% | -5.88% | -3.13% | +3.23% | -21.88% | +12% | -17.86% | +13.04% | -38.46% | +12.50% | -30.77% |
| 2018 | -6.50% | -31.55% | +5.47% | +2.96% | +0.72% | -35.00% | -12.09% | -12.50% | -24.29% | -26.42% | -23.08% | -13.33% | -87.00% |
| 2017 | +23.78% | +12.66% | +1.94% | -5.70% | +4.03% | -6.20% | +1.65% | -17.48% | -5.91% | -17.28% | +14.56% | +10.50% | +8.11% |
Drawdown analysis of Sonoma Pharmaceuticals (SNOA)
The maximum drawdown for the SNOA was -99.99%, occurring on Oct 26, 2023. This drawdown has not yet recovered.
The current SNOA drawdown is -99.99%.
Since Jan 25, 2007 SNOA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 2 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Jul 18, 2007 | 4098 | Oct 26, 2023 | Ongoing | Ongoing | Ongoing |
| -28.74% | Feb 23, 2007 | 27 | Apr 3, 2007 | 54 | Jun 20, 2007 | 81 |
| -13.68% | Jan 26, 2007 | 11 | Feb 12, 2007 | 8 | Feb 23, 2007 | 19 |
| -8.14% | Jun 21, 2007 | 2 | Jun 25, 2007 | 8 | Jul 6, 2007 | 10 |
| -0.23% | Jul 6, 2007 | 1 | Jul 9, 2007 | 1 | Jul 10, 2007 | 2 |